References
[1] Lazzerini PE, Capecchi PL, Laghi-Pasini F. Systemic inflammation
and arrhythmic risk: Lessons from rheumatoid arthritis. Eur Heart J
2017;38:1717-1727. https://doi.org/10.1093/eurheartj/ehw208.
[2] Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N,
et al. Accelerated atherosclerosis in autoimmune rheumatic diseases.
Circulation 2005;112:3337-3347.
https://doi.org/10.1161/CIRCULATIONAHA.104.507996.
[3] Lazzerini PE, Acampa M, Capecchi PL, Hammoud M, Maffei S,
Bisogno S, et al, Association between high sensitivity C-reactive
protein, heart rate variability and corrected QT interval in patients
with chronic inflammatory arthritis. Eur J Intern Med 2013;24:368-374.
http://doi.org/10.1016/j.ejim.2013.02.009.
[4] Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL,
Jacobsen SJ, Gabriel SE. Increased unrecognized coronary heart disease
and sudden deaths in rheumatoid arthritis: A population-based cohort
study. Arthritis Rheum 2005;52:402-411.
https://doi.org/10.1002/art.20853.
[5] Chauhan K, Ackerman MJ, Crowson CS, Matteson EL, Gabriel SE.
Population-based study of QT interval prolongation in patients with
rheumatoid arthritis. Clin Exp Rheumatol 2015;33:84.
[6] Kobayashi H, Kobayashi Y, Yokoe I, Kitamura N, Nishiwaki A,
Takei M, Giles JT. Heart rate–corrected qt interval duration in
rheumatoid arthritis and its reduction with treatment with the
interleukin 6 inhibitor tocilizumab. J Rheumatol 2018;45:1620-1627.
https://doi.org/10.3899/jrheum.180065.
[7] Lazzerini PE, Capecchi PL, Laghi-Pasini F. Long QT syndrome: An
emerging role for inflammation and immunity. Front Cardiovasc Med
2015;2:26. https://doi.org/10.3389/fcvm.2015.00026.
[8] Panoulas VF, Toms TE, Douglas KMJ, Sandoo A, Metsios GS,
Stavropoulos-Kalinoglou A, Kitas GD. Prolonged QTc interval predicts
all-cause mortality in patients with rheumatoid arthritis: An
association driven by high inflammatory burden. Rheumatology (Oxford)
2014;53:131-137. https://doi.org/10.1093/rheumatology/ket338.
[9] Seferović PM, Ristić AD, Maksimović R, Simeunović DS, Ristić GG,
Radovanović G, et al. Cardiac arrhythmias and conduction disturbances in
autoimmune rheumatic diseases. Rheumatology (Oxford) 2006;45(suppl.
4):iv39-iv42. https://doi.org/10.1093/rheumatology/kel315.
[10] Terao C, Hashimoto M, Yamamoto K, Murakami K, Ohmura K,
Nakashima R, et al. Three groups in the 28 joints for rheumatoid
arthritis synovitis - Analysis using more than 17,000 assessments in the
KURAMA database. PLOS ONE 2013;8:e59341.
https://doi.org/10.1371/journal.pone.0059341.
[11] Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R,
Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and
interpretation of the electrocardiogram. Part IV: The ST Segment, T and
U waves, and the QT interval A scientific statement from the American
Heart Association electrocardiography and Arrhythmias Co. J Am Coll
Cardiol 2009;53:982-991.
http://doi.org/10.1016/j.jacc.2008.12.014.
[12] Al-Khatib SM, LaPointe NMA, Kramer JM, Califf RM. What
clinicians should know about the QT interval. JAMA 2003;289:2120-2127.
https://doi.org/10.1001/jama.289.16.2120.
[13] Antikainen RL, Grodzicki T, Palmer AJ, Beevers DG, Webster J,
Bulpitt CJ. Department of Health and Social Security Hypertension Care
Computer Project (DHCCP). Left ventricular hypertrophy determined by
Sokolow–Lyon criteria: A different predictor in women than in men? J
Hum Hypertens 2006;20:451-459.
https://doi.org/10.1038/sj.jhh.1002006.
[14] Aletaha D, Smolen J. The simplified disease activity index
(SDAI) and the clinical disease activity index (CDAI): A review of their
usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol
2005;23(suppl. 39):S100-S108.
[15] Sordillo PP, Sordillo DC, Helson L. Review: The prolonged QT
interval: Role of pro-inflammatory cytokines, reactive oxygen species
and the ceramide and sphingosine-1 phosphate pathways. In Vivo
2015;29:619-636.
[16] Cacciapaglia F, Fornaro M, Venerito V, Perniola S, Urso L,
Iannone F. Cardiovascular risk estimation with 5 different algorithms
before and after 5 years of bDMARD treatment in rheumatoid arthritis.
Eur J Clin Investig 2020;50:1-8.
[17] da Mota LMH, Laurindo IMM, de Carvalho JF, dos Santos-Neto LL.
Prognostic evaluation of early rheumatoid arthritis. Swiss Med Wkly
2010;140:w13100. https://doi.org/10.4414/smw.2010.13100.
[18] Cui K, Movahedi M, Bombardier C, Kuriya B. Cardiovascular risk
factors are negatively associated with rheumatoid arthritis disease
outcomes. Ther Adv Musculoskelet Dis 2021;13:X20981217.
http://www.ncbi.nlm.nih.gov/pubmed/1759720.
[19] Kitas GD, Gabriel SE. Cardiovascular disease in rheumatoid
arthritis: State of the art and future perspectives. Ann Rheum Dis
2011;708-14. https://doi.org/10.1136/ard.2010.142133.
[20] Mason JC, Libby P. Cardiovascular disease in patients with
chronic inflammation: Mechanisms underlying premature cardiovascular
events in rheumatologic conditions. Eur Heart J 2015;36:482-49c.
https://doi.org/10.1093/eurheartj/ehu403.
[21] Dekkers JC, Geenen R, Godaert GL, Bijlsma JW, van Doornen LJ.
Elevated sympathetic nervous system activity in patients with recently
diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol
2004;22:63-70.
[22] Murphy SP, Kakkar R, McCarthy CP, Januzzi JL. Inflammation in
heart failure: JACC state-of-the-art review. J Am Coll Cardiol
2020;75:1324-1340. https://doi.org/10.1016/j.jacc.2020.01.014.
[23] Tomaselli GF, Zipes DP. What causes sudden death in heart
failure? Circ Res 2004;95:754-763.
https://doi.org/10.1161/01.RES.0000145047.14691.db.
[24] Karpouzas GA, Malpeso J, Choi TY, Li D, Munoz S, Budoff MJ.
Prevalence, extent and composition of coronary plaque in patients with
rheumatoid arthritis without symptoms or prior diagnosis of coronary
artery disease. Ann Rheum Dis 2014;73:1797-1804.
https://doi.org/10.1136/annrheumdis-2013-203617.
[25] Puntmann VO, Taylor PC, Barr A, Schnackenburg B, Jahnke C,
Paetsch I. Towards understanding the phenotypes of myocardial
involvement in the presence of self-limiting and sustained systemic
inflammation: A magnetic resonance imaging study. Rheumatology
2009;49:528-535. https://doi.org/10.1093/rheumatology/kep426.
[26] Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB.
Precordial QT interval dispersion as a marker of torsade de pointes.
Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
Circulation 1992;86:1376-1382.
https://doi.org/10.1161/01.cir.86.5.1376.